AA
NURO

AlphaMark Advisors’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

AlphaMark Advisors’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3
Closed – – 522
2019
Q2 		$0 Hold
3
– – ﹤0.01% 533
2019
Q1 		$0 Hold
3
– – ﹤0.01% 520
2018
Q4 		$0 Hold
3
– – ﹤0.01% 517
2018
Q3 		$0 Hold
3
– – ﹤0.01% 548
2018
Q2 		$0 Buy
+3
New +$331 ﹤0.01% 550

Other funds holding NURO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RIA
Realta Investment Advisors Wilmington, Delaware $322M AUM 39.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFS
Orrstown Financial Services Harrisburg, Pennsylvania $674M AUM 23.23% 1-Year Est. Return
RC
Randolph Company Cincinnati, Ohio $1.19B AUM 38.92% 1-Year Est. Return

AlphaMark Advisors's NURO Position: Q3 2019 in Review

AlphaMark Advisors sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q3 2019, closing a stake of 3 shares.

AlphaMark Advisors first reported a position in NURO in Q2 2018 and held it in 5 quarters. The position peaked at $0 in Q2 2019. 12 funds tracked by Wall St. Rank hold NURO as of Q3 2019.

  • AlphaMark Advisors reported no remaining NeuroMetrix, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • AlphaMark Advisors sold 3 NeuroMetrix, Inc. Common Stock shares in Q3 2019.
  • AlphaMark Advisors first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • AlphaMark Advisors's NeuroMetrix, Inc. Common Stock position peaked at $0 in Q2 2019.
  • 12 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q3 2019.

Based on AlphaMark Advisors's 13F filing for Q3 2019, filed 1 Nov 2019.